Pharmaceutical products

Tender description

Northumberland, Tyne and Wear NHS Foundation Trust (NTW) have successfully bid for a HTA funding to run a National, multi-site, placebo controlled clinical trial looking a pramipexole use in 290 patients with treatment resistant bipolar depression. This will require the manufacture of matching placebo tablets to pramipexole and the blinding of active pramipexole tablets. The trial will be run by the Regional Affective Disorders Outpatient Service. This is a specialist / tertiary level affective disorders service which provides care for patients with complex and / or treatment refractory affective disorders and other treatment refractory conditions complicated by an affective component. For further information and to access tender documents please express interest via the following link: https://procontract.due-north.com/Advert/Index?advertId=173d5a00-924c-e811-80eb-005056b64545. Northumberland, Tyne and Wear NHS Foundation Trust (NTW) have successfully bid for a HTA funding to run a National, multi-site, placebo controlled clinical trial looking a pramipexole use in 290 patients with treatment resistant bipolar depression. This will require the manufacture of matching pla...ective disorders service which provides care for patients with complex and/or treatment refractory affective disorders and other treatment refractory conditions complicated by an affective component. Time Frames. 1 Trial start date: April 2018 (7 months pre-randomisation) 2 Delivery of first batch of IMP – To be advised 3 Delivery of second batch of IMP – To be agreed 4 Study length: 4 years 5 First patient randomisation: November 2018 6 Last patient randomisation: March 2021